Jarrod M. Patten

This profile gathers the share dealings of Jarrod M. Patten across 2 companies, led by Strategy Inc and Core Scientific, Inc./tx. In total, 115 filings cover trades dated from 2 August 2021 to 9 October 2026.

Both buying and selling appear: 12 purchases worth €3.2M, against 39 sales worth €4.1M. Sales outweigh purchases by €938k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants and 62 option exercises. In 2026 alone, the filings show no purchases and 37 sales.

The median purchase comes to €55k. On 9 out of 12 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 9 purchases show a median change of +66.4%, with the price up in 89% of them. These figures describe past trades and do not predict future prices.

On 13 October 2026 came the latest disclosure, an option exercise for €23k in Strategy Inc. The most recent open-market purchase was published on 20 October 2025, 363 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.